The global rapid food safety testing market, valued at $19.66 billion in 2025, is forecast to grow at a CAGR of 9.7%, reaching $31.22 billion by 2030. Increasing demand for convenience foods, subject ...
Germany, France, and the UK lead the IVD market due to robust healthcare systems and government support. Key trends include personalized medicine, digital health, and the adoption of rapid and ...
The evening before I sat down to speak to Andy Ryan he was watching Arsenal play Atletico Madrid at The Emirates Stadium with ...
Toxoplasma gondii poses serious risks during pregnancy and to those with weakened immune systems, and Clinicians must ...
Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, announced the launch of the RNA Module for Countable PCR. This new solution brings ...
One Government source described how “there were rumours flying that you could buy an exam paper for €50 the night before an ...
According to Mordor Intelligence, the global companion diagnostics market is valued at USD 8.70 billion in 2025 and is projected to surpass USD 15.62 billion by 2030, growing at a CAGR of 12.42% ...
Eight Nova Scotians died from COVID-19 the week of Aug. 16 to 22, the province's updated COVID-19 dashboard showed Thursday. There were an average of 194 daily COVID-19 cases confirmed by PCR testing ...
The Global Point-of-Care Molecular Diagnostics Market is projected to grow at a CAGR of 10.2% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals ...
Your dog sneezed 9 times before breakfast: harmless autumn itch or a £65 vet bill waiting to happen?
Cold mornings, radiators humming, and a chorus of snorts from the sofa raise quiet doubts in countless British homes. As ...
In the wake of the rising threat of dengue, a high-level meeting was held at Nishtar Hospital, where officials discussed the ...
First study to evaluate HER2DX in a randomized trial focused exclusively on older individuals (aged 70-80 years). HER2DX independently predicts long-term survival outcomes in patients treated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results